Li, Tian-Xiao Gao, Bu-Lang Cai, Dong-Yang Wang, Zi-Liang Zhu, Liang-Fu Xue, Jiang-Yu Bai, Wei-Xing He, Ying-Kun Li, Li Disabling or fatal stroke rate within and beyond 30 days in the SAMMPRIS study. <p>Note:</p><p><sup>#</sup> The disabling or fatal stroke rates within 30 days could be found in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0139377#pone.0139377.t003" target="_blank">Table 3</a> in reference <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0139377#pone.0139377.ref008" target="_blank">8</a>.</p><p>* The disabling or fatal stroke rates at the end of 32.4 months of follow-up for both groups could be found in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0139377#pone.0139377.t003" target="_blank">Table 3</a> in reference <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0139377#pone.0139377.ref009" target="_blank">9</a>.</p><p>** The number of patients with disabling or fatal stroke beyond 30 days was 21–16 = 5 for the PTAS group but 18–4 = 14 for the MED group, whereas the number of patients who finished the follow-up was 191 for the PTAS group and 210 for the MED group (see the Results of reference <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0139377#pone.0139377.ref009" target="_blank">9</a>). PTAS: percutaneous transluminal angioplasty and stenting; MED: medical management group.</p><p>Disabling or fatal stroke rate within and beyond 30 days in the SAMMPRIS study.</p> intracranial atherosclerotic stenosis;lt;ias;stroke rate;hemorrhagic stroke rate;intracranial Wingspan stenting;Single Medical Center PurposeTo;433 Patients Treated;basilar artery area;perioperative stroke rate;MethodsBetween July 2007 2015-09-30
    https://plos.figshare.com/articles/dataset/_Disabling_or_fatal_stroke_rate_within_and_beyond_30_days_in_the_SAMMPRIS_study_/1560373
10.1371/journal.pone.0139377.t005